|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preclinical, pharmacologic and phase Ⅰ studies of gemcitabine显示文摘 | Storniolo Am Allerheiligen SBR Pearce HL | 1997 | Semin Oncol1997，24，2： | 1 |
| 2 | Preclinical,pharmacologic and phase I studies of gemcitabine显示文摘 | Storniolo AM Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，1： | 1 |
| 3 | Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies显示文摘 | Dahlem AM Allerheiligen S R Vodicnik M J | 1995 | Toxicol Pathol1995，23，2： | 1 |
| 4 | Preclinical,pharmacologic, and phase I studies of gemcitabine 显示文摘 | Stomiolo AM Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，1： | 1 |
| 5 | In season strength training for power athletes 显示文摘 | Allerheiligen B | 2003 | Strength Cond J2003，25，3： | 1 |
| 6 | Preclinical,pharmacologic and phase I studies of gemcitabine显示文摘 | Storniolo Am Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，： | 1 |
| 7 | Concomitant toxicokinetics:techniques for and interpretation of exposure data obtained during the conduct of toxicology studies显示文摘 | Dahlem AM Allerheiligen SR Vodicnik MJ | 1995 | Toxicol Pathol1995，23，2： | 1 |
| 8 | Preclinical, pharmacologic, and phase I studies of gemcitabine 显示文摘 | Storniolo AM Allerheiligen SR Pearce HL | 1997 | Semin Oncol1997，24，27： | 1 |
| 9 | Preelinieal, pharmacologic and phase 1 studies fo gemeitabine 显示文摘 | Stomiolo Am Allerheiligen SBR Pearce HL | 1997 | Semin Oncol1997，24，2： | 1 |
| 10 | Preclinical,pharmacologic and phase I studies of gemcitabine显示文摘 | Storniolo AM Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，1： | 1 |
| 11 | Preclinical, pharmacologic and phase I studies of gemeitabine 显示文摘 | Storniolo A M Allerheiligen S Pearce H L | 1997 | Semin Oncol1997，24，1： | 1 |
| 12 | Preclinical,pharmacologic and phase I studies of Gemcitabine显示文摘 | STORNIOLO A M ALLERHEILIGEN S R PEARCE H L | 1997 | Semin Oncol1997，24，27： | 1 |
| 13 | Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori 显示文摘 | Cambau E Allerheiligen V Coulon C Corbel C Lascols C Deforges L Soussy CJ Delchier JC Megraud F | 2009 | J Clin Microbiol2009，47，11： | 1 |
| 14 | Preclinical, pharmacologic and phase Ⅰ studies of gemcitabine 显示文摘 | Storniolo AM Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，： | 1 |
| 15 | Preclinical,pharmacologic,and phase Ⅰ studies of gemcitabine显示文摘 | Storniolo AM Allerheiligen SR Pearce HL | | 0，，： | 1 |
| 16 | Preclinical, pharmacologic and phase Ⅰ studies ofgemcitabine显示文摘 | Storniolo AM Allerheiligen S Pearce HL | 1997 | Semin Oncol1997，24，： | 1 |
| 17 | Preclinical, pharmaco-logic, and phase I studies of gemcitabine 显示文摘 | Storniolo AM Allerheiligen SR Pearce HL | 1997 | Semin Oncol1997，24，27： | 1 |
| 18 | Preclinical, pharmacologic and phase 1 studies of gemcitabine 显示文摘 | Storniolo AM Allerheiligen SBR Pearce HL | 1997 | Semin Oncol1997，24，2： | 1 |
| 19 | Preclinical,pharmacologic and phase Ⅰ studies of gemcitabine显示文摘 | Storniolo A M Allerheiligen S B R Pearce H L | 1997 | Semin Oncol1997，24，27： | 1 |
| 20 | Gemcitabine pharmacokinetics are influenced by gender,body surface area (BSA),and duration of infusion显示文摘 | Allerheiligen S Johnson R Hatcher B Freeman K Tarassoff P Voi M | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员